
Gian Life Care Ltd Schedules Board Meeting to Approve Q3 Results for FY2025-26
Gian Life Care Ltd has informed the BSE that its Board of Directors will meet on January 24, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended September 30, 2025. The meeting, originally scheduled for February 21, 2026, has been rescheduled. The trading window for dealing in shares of the company has been closed for Directors, KMP’s, Designated Employees and Connected Persons from October 1, 2025, and will remain closed till 48 hours after the information is made public.
Key Highlights
- Gian Life Care Ltd to consider and approve Q3 FY2025-26 results on January 24, 2026
- Meeting rescheduled from February 21, 2026
- Trading window for shares closed from October 1, 2025, for Directors, KMP’s, Designated Employees and Connected Persons
Price Impact
More from GIANLIFE
Gian Life Care Ltd Enters Hospital Lab Management Services Agreement with Brahma Hospital (HUF)
Gian Life Care Ltd Announces Q3 2025 Results with ¥ 743.78 Lakhs Cash Balance and Unpaid Dues
Gian Life Care Ltd. Approves Q3 Results with Cash Balance of ₹ 743.78 Lakhs and Unpaid Dues of ₹ 426.66 Lakhs and ₹ 359.78 Lakhs